NCT00237146View on ClinicalTrials.gov

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Prostate Cancer
Interventions
DRUG

Zoledronic acid

Trial Locations (1)

Unknown

Novartis Investigative Site, Caracas

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT00237146 - Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy | Biotech Hunter | Biotech Hunter